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Abstract 
 Mild traumatic brain injury (mTBI) is a common occurrence, and may impact distal outcomes in 
a subgroup of individuals. Improved characterization of health outcomes and identification of factors 
associated with poor outcomes is needed to better understand the impact of mTBI, particularly in those 
with co-occurring posttraumatic stress disorder (PTSD). Participants in a data repository of the Injury 
and Traumatic Stress (INTRuST) Clinical Consortium (N=625) completed functional disability [FD] and 
health-related quality of life [HRQOL] questionnaires, and a subset completed a neuropsychological 
assessment. FD and HRQOL were compared among participants with probable mTBI (mTBI), probable 
mTBI with PTSD (mTBI/PTSD), and health comparison participants (HC). Associations between 
symptoms, neuropsychological performance, and health outcomes were examined in those with 
probable mTBI with and without PTSD (n=316). Individuals in the mTBI/PTSD group endorsed poorer 
health outcomes than those in the mTBI group, who endorsed poorer outcomes than those in the HC 
group. Individuals in either mTBI group performed worse than those in the HC on verbal learning and 
memory and psychomotor speed. Health outcomes were correlated with mental health and 
postconcussive symptoms, as well as neuropsychological variables. mTBI may adversely impact self-
reported health, with the greatest effect observed in individuals with co-occurring mTBI/PTSD.   
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1. Introduction 
Traumatic brain injury (TBI) occurs when a force to the head (e.g., blunt injury, blast) causes 
alteration of consciousness (AOC) or loss of consciousness (LOC), posttraumatic amnesia, neurological 
deficits, and/or intracranial lesion (Bryant et al., 2010). TBI is highly prevalent, with the Centers for 
Disease Control and Prevention estimating approximately 1.7 million cases per year (Faul, 2010). Mild 
TBI (mTBI), which is the most typical variant of TBI, is defined by the American College of Rehabilitation 
Medicine (ACRM) as an injury associated with LOC for less than 30 minutes, less than 24 hours of 
posttraumatic amnesia, and a Glasgow Coma Scale rating of 13-15 (Bazarian et al., 2005). mTBI exposure 
can be associated with a host of physical (e.g. headache), cognitive, and mental health (e.g., depression, 
PTSD) sequelae. Typically symptoms resolve naturally over a short timeframe (McRory et al., 2013),  but 
a subgroup of individuals report emotional, cognitive, or functional symptoms following the acute 
recovery phase (Boyle et al., 2014; O'Neil et al., 2017; Stein et al., 2016; Vasterling et al., 2017). For 
example, Jak and colleagues found in a sample of 411 veterans with a history of probable mTBI that 
average mental health symptom scores fell in the clinical range and 28% demonstrated impaired 
neuropsychological performance on two or more tests (Jak et al., 2015), while  McMahon and colleagues 
found that 22.6% of civilian individuals with mild TBI reported functional and postconcussive symptoms 
one year post-injury (McMahon et al., 2014). The etiology of chronic symptoms may be attributable to 
non-concussive factors (e.g., pre-existing or new onset psychiatric disorders (Donnell et al., 2012; 
Lagarde et al., 2014)) and remains a controversial topic (for reviews see (Broshek et al., 2015; Hoge et 
al., 2009; Silverberg and Iverson, 2011)). Irrespective of the source of chronic symptoms, improved 
characterization of global health outcomes in this group, as well as identification of factors associated 
with poor health outcomes, is needed to better understand the broad impact of mTBI.  
Two commonly used metrics to assess health status outcomes include functional disability (FD) 
and health-related quality of life (HRQOL). FD refers to the impact of a particular disease state on one’s 
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ability to conduct activities of daily living, including work or social functioning. FD reflects an evaluation 
of the burden of a particular condition (Nichol et al., 2011). Though precise definitions of HRQOL are not 
universally agreed upon, the World Health Organization considers HRQOL to be the individual’s 
“perception of their position in life in the context of the culture and value systems in which they live and 
in relation to their goals, expectations, standards and concerns” (Kuyken et al., 1995). Thus, although 
HRQOL is similar to FD in its assessment of the extent of a problem’s impact, it can be conceptualized as 
a subjective or contextualized report of the experience relative to the individual’s ideal (Nichol et al., 
2011). 
mTBI has been associated with higher levels of FD (Scholten et al., 2015; Whiteneck et al., 2016) 
and lower ratings of HRQOL in individuals with a history of mTBI as compared to healthy comparison 
participants (Ahman et al., 2013; Beseoglu et al., 2013; Dijkers, 2004; Emanuelson et al., 2003). A recent 
review by Polinder and colleagues (Polinder et al., 2015) noted a substantial degree of variability in 
functional outcomes within individuals with TBI, highlighting the need to examine predictors of HRQOL 
within this group of individuals (see also (Petchprapai and Winkelman, 2007)). Although diminished FD 
and HRQOL have been found in studies of mTBI, clinical variables that are associated with FD and HRQOL 
in mTBI have been understudied to date.  
FD and HRQOL outcomes following mTBI likely depend on multiple external (e.g., environment) 
and internal factors, including mental health variables (Kay, 1992).  Jackson and colleagues recently 
reported that veterans with mTBI and PTSD, but not veterans with mTBI only, differed from healthy 
comparison participants on a measure of psychosocial functioning (Jackson et al., 2016), suggesting that 
psychiatric symptoms are a primary contributor to health outcomes. Although data on non-military 
samples is limited, a study by Haagsma and colleagues reported associations between higher self-
reported PTSD symptoms and worse HRQOL and FD in a civilian mTBI sample (Haagsma, 2015). 
Postconcussive symptoms (PCS) might also contribute to poor perceived health status. PCS include a 
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constellation of cognitive, sensory, emotional, and physical complaints that the individual reports as 
beginning after head injury. PCS are associated with ratings of FD and HRQOL in individuals with mTBI 
(Emanuelson et al., 2003; Schiehser et al., 2015). However, their high overlap with mental health 
symptoms (Belanger et al., 2010) and non-specific nature (Cassidy et al., 2014) raises the possibility that 
psychological distress, rather than mTBI-specific problems, is the etiological factor linking them to lower 
health ratings. To date, studies examining FD and HRQOL have not reported separately on psychiatric 
symptoms and postconcussive symptoms when examining the relationship of each to subjective ratings 
of health outcomes.  
Neuropsychological factors may also be associated with ratings of FD and HRQOL in individuals 
with mTBI, yet this possibility has been understudied. Extant literature is mixed with regard to 
neuropsychological impairments observed in mTBI. Some studies suggest those with mTBI demonstrate 
modest performance reductions in specific domains (attention, working memory, memory, executive 
functioning) suggesting that some individuals may have persistent cognitive symptoms following mTBI 
(Dean and Sterr, 2013; McInnes et al., 2017). However, a number of other reviews suggest that 
neuropsychological impairments are not apparent in mTBI, and authors have noted that the high co-
occurrence of psychiatric complaints and invalid effort performance may impact testing performance in 
those with mTBI (Albrecht et al., 2016; Dolan et al., 2012; Frencham et al., 2005; Jak et al., 2015; Rohling 
et al., 2011; Verfaellie et al., 2014). Data examining the impact of neuropsychological performance on 
HRQOL and FD in mTBI is limited, but cognitive functioning has been shown to predict worse health 
outcomes in other mental and physical health conditions (Andreou and Bozikas, 2013; Brissos et al., 
2008; Meneses et al., 2009). In one published study, Martindale and colleagues (Martindale et al., 2016) 
assessed relationships between neuropsychological performance and HRQOL in a veteran sample. The 
authors found inverse relationships between HRQOL and executive functioning, verbal memory, and 
motor processing. However, these relationships did not hold when accounting for PTSD and mTBI status 
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(see also (Disner et al., 2017)). It remains to be established whether neuropsychological variables predict 
health status outcomes for those with mTBI who perform credibly during testing, and how 
neuropsychological and health status variables are related in non-veteran samples.  
The goals of the current study were two-fold. First, we sought to compare FD and HRQOL ratings 
among individuals with probable mTBI (with and without PTSD) as compared to healthy comparison 
participants using a large multi-study repository dataset collected as part of the INjury and TRaUmatic 
STress (INTRuST) PTSD/TBI Clinical Consortium (W81XWH-08-2-0159). The dataset included participants 
characterized as having probable mTBI and no PTSD diagnosis (mTBI group) and both probable mTBI and 
PTSD diagnoses (mTBI/PTSD group), which allowed for examination of group difference on the selected 
health status outcomes (FD and HRQOL) and relevant neuropsychiatric variables (i.e., mental health 
symptoms, postconcussive symptoms, neuropsychological performance). Unlike prior studies, these 
individuals were heterogeneous in terms of civilian, military, or veteran status. Second, we sought to 
examine associations between ratings of FD and HRQOL and the neuropsychiatric variables within 
individuals with probable mTBI (irrespective of PTSD status), including mental health symptoms (PTSD, 
depression, general distress), PCS symptoms, and neuropsychological functioning. To build on prior 
work, we examined these variables separately to better understand the contribution of each. Consistent 
with earlier work showing the adverse impact of psychiatric distress on health outcomes (Haagsma, 
2015; Jackson et al., 2016), we anticipated that individuals with probable mTBI and PTSD would endorse 
greater FD and lower HRQOL relative to those without probable mTBI. In line with prior literature 
(Emanuelson et al., 2003; Haagsma, 2015) we also hypothesized that mental health symptoms, 
postconcussive symptoms, and neuropsychological functioning would contribute to FD and HRQOL 
within the patient groups.  
2. Methods 
2.1 Participants 
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Participants were 625 individuals in the INTRuST phenotypic data repository which involved 
completion of questionnaires and provision of a biological sample (data from additional aims of the 
repository are reported elsewhere). Participants consisted of individuals who enrolled in one of the 
INTRuST IRB-approved studies and agreed to participate in this supplemental phenotypic repository or 
individuals recruited specifically for the repository. Participants completed standardized assessments of 
mental health symptoms, health status outcomes, possible TBI history, and PCS. All measures utilized in 
the current analyses were collected as part of the baseline or screening visit of the parent trial in which 
the individual was enrolled, prior to the participant receiving study intervention. Only the 625 
individuals who had complete data on health status and symptom variables were included in analyses 
(out of 702 individuals who completed the study consent). Study participants were divided in three sub-
groups: Healthy comparison participants (HC; n = 309, neuropsychological data collected for 49.8% (n = 
156)); mTBI only (n = 183, with neuropsychological data for 64.5% (n = 120); and mTBI/PTSD (n = 133, 
with neuropsychological data for 61.7% (n = 84)).  
Inclusion and exclusion criteria were based in part on the individual INTRuST studies in which 
participants were enrolled (detailed in Supplemental Materials). Specific exclusions for participation in 
this phenotypic repository in the patient groups were 1) lifetime bipolar I disorder, lifetime psychotic 
disorders, lifetime dementia, delirium, alcohol or other substance dependence (within 30 days), 2) CNS 
disorders including aneurysm, anoxic events, brain tumor, encephalitis, Guillain Barre syndrome, 
Huntington’s disease, hydrocephalus, uncontrolled diabetes, thyroid condition or blood pressure, 
multiple sclerosis, Parkinson’s disease, seizure disorder, stroke, or subdural hematoma, 3) currently 
pregnant or lactating (due to effects of hormonal fluctuations on biological samples collected as part of 
the repository). For the subgroup of participants who completed a neuroimaging component as part of a 
separate aim of the repository (n = 363) additional exclusion criteria also included: 1) current 
medications that affect the brain function as determined by the study physician, 2) English as a second 
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language after the age of 5, 3) history of a learning disability, and 4) weight of more than 300 pounds as 
this would preclude the subject from entering the scanner. 
Each study site recruited healthy comparison participants between the ages of 18 and 65 by 
using media advertising (Facebook, Craigslist, Yahoo) and registries containing individuals interested in 
research participation. Responders were briefly screened over the phone for obvious exclusion criteria 
(e.g., currently taking psychoactive medication, pregnancy). Exclusions for healthy comparison 
participants included the 1) CNS disorders as described above, 2) medication exclusions, including more 
than one antihypertensive drug, psychotropic drugs within the last 90 days, herbal psychoactive 
substance use, or steroid use in the last 4 months, 3) currently pregnant or lactating, 4) history of mood, 
anxiety, psychotic, dementia, delirium, substance dependence in the past 12 months, 5) history of 
probable TBI as defined by the I-TBI. Those who initially met inclusion criteria on the phone screen were 
invited for an in-person qualifying interview (MINI International Neuropsychiatric Interview 6.0.0; MINI 
(Sheehan et al., 1998)) to ensure that the potential participant qualified as a healthy comparison 
participant for this study (n = 309). 
2.2 Measures 
2.2.1. TBI History. History of probable TBI was assessed using a self-report questionnaire with 
items corresponding to the diagnostic criteria of the ACRM (ACRM, 1993). Participants were asked to 
identify any history of head injury across various categories (e.g., blast, fall). In cases where the 
individual experienced a head injury, he/she was indicated if they experienced indications of a probable 
mTBI as a result. Individuals considered positive for probable mTBI endorsed a history of head injury 
that resulted in one or more of the following: alteration in consciousness (AOC), loss of consciousness 
(LOC), or posttraumatic amnesia (PTA). The specifier of probable mTBI was created based on duration of 
AOC/LOC and PTA as per the ACRM guidelines. 
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2.2.2. Functional disability. Health-related functional disability was assessed using the Sheehan 
Disability Scale (SDS (Sheehan et al., 1996)). The SDS is a 3-item questionnaire that assesses the extent 
to which health status impacts activities of daily living, including impairment in work, social, and family 
domains, which are summed to create a continuous total score ranging from 0 to 30. Higher values 
indicate a greater level of disability. The measure possesses adequate psychometric properties (Sheehan 
et al., 1996).  
2.2.3. HRQOL. Mental and physical HRQOL were assessed using the Short Form 12-item Health 
survey (SF-12 (Ware et al., 1996)). The global mental health (MCS-12) and physical health (PCS-12) 
subscales were calculated with the Quality Metric scoring algorithm. The SF-12 is a shortened version of 
the Short Form 36 health survey (SF-36), which is a validated measure of HROQOL that evaluates 
subjective report of the experience of a given problem or condition, and the summary scores selected 
have demonstrated good validity in contrasting health status across groups (Ware, 2002). The scales 
range from 0 to 100 with higher ratings indicating better global mental health and global physical health. 
2.2.4. PTSD symptoms and diagnostic status. The PTSD Checklist-Civilian Version (PCL-C 
(Weathers et al., 1993)) was administered to assess continuous PTSD symptom severity relative to the 
individual’s worst traumatic experience. The PCL-C is a 17-item measure assessing PTSD symptoms, with 
items corresponding to diagnostic criteria for PTSD outlined in the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition (DSM-IV). All items are rated on a scale from 1 (not at all bothersome) to 5 
(extremely bothersome) and are totaled by summing symptom severity items (range: 17 to 85). 
Validation studies indicate that the PCL-C has sound psychometric properties (Weathers et al., 1993). 
Each participant was assigned a current PTSD diagnosis determined using the procedure of the parent 
study, which relied on use of a PCL-C cutoff (50) (n = 30)  and/or a diagnostic interview using the 
Clinician Administered PTSD Scale (Blake et al., 1995) (n = 35), or the MINI 6.0.0 (Sheehan et al., 1998) (n 
= 234).  
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2.2.5. Depression symptoms. Depression was assessed using the Patient Health Questionnaire-9 
(PHQ9 (Kroenke et al., 2001)). The PHQ9 contains 9 items assessing depressive symptoms on a scale 
from 0 (not at all) to 3 (nearly every day). Items are summed to create a continuous total severity score, 
and the scale possesses excellent reliability, criterion validity and construct validity (Kroenke et al., 
2001). 
2.2.6. General distress symptoms. The Brief Symptom Inventory-18 (BSI-18) Global Severity 
Index (GSI) was used to assess continuous depression, anxiety, and somatization symptoms. Raw scores 
were converted to age- and gender-normed T-scores, with T ≥ 63 considered clinical elevation. The BSI-
18 has established psychometric properties, including high correspondence with the parent BSI and 
Symptom Checklist-90-R (Derogatis, 2001).  
2.2.7. Postconcussive Symptoms. The Rivermead Post Concussion Symptoms Questionnaire 
(RPQ (King et al., 1995)) was used to assess PCS in individuals who had experienced probable mTBI. The 
RPQ contains 16 questions assessing the severity and number of emotional, cognitive, and somatic 
complaints experienced after head injury. Symptoms were summed within two subscales (RPQ-3 and 
RPQ-13) based on the recommendations of Eyres and colleagues (Eyres et al., 2005).  The RPQ-3 
measures headaches, dizziness and nausea, while the RPQ-13 measures remaining emotional (e.g., 
feeling depressed or tearful), cognitive and somatic symptoms. As part of the questionnaire, participants 
indicate the presence of symptoms since the identified head injury; however the etiology of symptoms 
cannot be definitively characterized based on self-report. 
2.2.8. Neuropsychological functioning. A subset of individuals (n = 360) completed a battery of 
neuropsychological tests to assess visual and verbal learning and memory (Brief Visuospatial Memory 
Test-Revised [BVMT-R] total, learning, and long delay recall scores (Benedict, 1997); Rey Auditory Verbal 
Learning Test -2 [RAVLT-2] total, list B, short and long delay recall scores (Schmidt, 1996; Strauss, 2006)), 
attention and working memory (Wechsler Memory Scales-III Letter Number Sequencing [WMS-III LNS] 
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(Wechsler, 1997); Paced Auditory Serial Addition Test [PASAT] number correct (Gronwall, 1977)), 
psychomotor processing speed (Trail Making Test-A (Reitan, 1993); Wechsler Adult Intelligence Scale-III 
[WAIS-III] Digit Symbol Coding and Symbol Search (Wechsler, 1997)), executive functioning (Trail Making 
Test-B (Reitan, 1993)), and academic achievement (Wide Range Achievement Test-4 [WRAT-4] Reading 
subtest (Wilkinson and Robertson, 2006)). Standardized z, T, or scaled scores with demographically 
corrected norms were calculated for each test using guidelines from the respective administration 
manuals for all tests, except the PASAT for which a residualized score was calculated using a regression 
model adjusting for age and education (see Table 2 for a full description of subtests used and normed 
scores by group). Embedded performance validity metrics were used to evaluate effort and validity 
during testing, and included the Trail Making Test (total time > 170), BVMT-R (recognition hits < 5), and 
RAVLT-2 recognition (<10) (Denning, 2012; Shura et al., 2016; Whitney and Davis, 2015). Individuals 
were required to pass at least two of the three embedded validity measures to be included in the 
neuropsychological testing analysis ((Larrabee, 2008; Meyers et al., 2014; Meyers and Volbrecht, 2003) 
in cases where data from one of the validity tests was missing, participants were required to pass all 
validity tests given; a total of 30 participants failed only on PVT: HC n = 7, mTBI n = 16, mTBI/PTSD n = 7). 
As a result, n = 15 were removed resulting in a final sample of n = 345.  
2.3. Statistical analyses 
Differences in demographic, health status outcome, mental health symptom, and 
neuropsychological performance variables across the three groups were analyzed using analysis of 
variance (ANOVA) for continuous variables and chi-square tests for categorical variables. Models 
analyzing symptom variables controlled for age and education. Models analyzing neuropsychological 
variables controlled for age and gender either by using normed scores or by including the demographic 
variable as a covariate in the model. Models of neuropsychological variables also controlled for 
academic achievement to account for the possibility that differences in academic history impacted 
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scores. Individuals with missing data points for specific neuropsychological tests were excluded listwise 
(missing data for subtests varied from <1% to 25%). Injury characteristics were collected on a subgroup 
of participants, and analysis of correlations between injury characteristics and the measured 
neuropsychiatric variables showed few statistically significant associations (see supplemental materials). 
Follow-up paired samples were conducted with error rates controlled by Bonferroni correction. Bivariate 
correlational analyses were conducted to evaluate the associations between each of the 
neuropsychiatric variables and HRQOL and FD outcomes in the patient groups (those with probable 
mTBI with or without PTSD).   
3. Results 
 Table 1 presents baseline demographic and clinical characteristics of participants in each group. 
Individuals in the HC group were significantly younger than individuals in the mTBI and mTBI/PTSD 
groups, who did not differ from each other. Individuals in the mTBI/PTSD group had significantly fewer 
years of education than those in the mTBI and HC groups. The mTBI/PTSD and mTBI groups had 
significantly fewer women than the HC group. For symptoms of PTSD, depression, and general distress, 
individuals in the mTBI/PTSD group endorsed significantly higher symptoms than those in the mTBI 
group and the HC group, and individuals in the mTBI group endorsed significantly higher symptoms than 
those in the HC group. Consistent with our hypotheses, individuals in the mTBI/PTSD group reported 
significantly lower physical and mental HRQOL, and significantly higher FD than those in the mTBI group 
and HC group. Individuals in the mTBI group reported significantly lower HRQOL and higher FD than 
those in the HC group (see Tables 1 and 3; See supplemental materials for results of analyses of 
symptom outcomes when controlling for general distress). In terms of neuropsychological findings, 
groups differed on tests of verbal learning and long-delay recall, and tests of psychomotor processing 
speed (Trails A, Digit Symbol Coding, Symbol Search). Individuals in mTBI/PTSD and mTBI groups 
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generally attained significantly lower scores than those in the HC group, and the mTBI and mTBI/PTSD 
groups did not differ statistically from each other (see Tables 2 and 3).   
Associations between clinical and demographic variables were evaluated to identify factors 
related to ratings of health status outcomes in those with probable mTBI, with or without PTSD (Table 
4). Age was associated with FD and physical HRQOL, and education was associated with mental HRQOL. 
All measured mental health symptoms and PCS were associated with FD and HRQOL ratings. Clinical 
symptoms, including PCS, were also highly inter-correlated. Associations between neuropsychological 
performance and health outcomes are reported in Table 5. Lower physical HRQOL was associated with 
lower verbal learning, short-delay verbal memory, visuospatial memory, and the WAIS-III psychomotor 
processing speed test scores. Higher FD was associated with lower WAIS-III psychomotor processing 
speed test scores. Lower mental HRQOL was associated with lower Digit Symbol test performance only.  
Mental health symptoms (BSI, PCL-C, PHQ9) correlated with performance on tests of verbal learning, 
processing speed, executive functioning, and attention, but not visuospatial performance. Associations 
between injury characteristics and neuropsychiatric variables, as well as correlations between mental 
health and PCS symptoms controlling for number of injury events are reported in the supplemental 
materials). 
4. Discussion 
mTBI is a relatively common injury that has been previously associated with lower ratings of 
health status outcomes. The current study examined differences in FD and HRQOL across three groups: 
healthy comparison participants, individuals with probable mTBI, and individuals with probable mTBI 
and co-occurring PTSD. Results revealed that individuals with probable mTBI, particularly those with co-
occurring PTSD, reported higher FD and lower HRQOL relative to healthy comparison participants. For 
individuals with probable mTBI (with or without PTSD), all mental health symptoms were strongly 
correlated with FD and HRQOL. Neuropsychological assessment data in individuals who passed 
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performance validity tests indicated that aspects of memory and psychomotor processing speed 
performance were modestly associated with health outcomes in individuals with probable mTBI.  
Mental health symptoms of general distress, depression, and PTSD have been linked to self-
report of health status in individuals with a history of mTBI in previous studies (Seidl et al., 2015; 
Steadman-Pare et al., 2001; Williamson et al., 2013).  PCS were also associated with lower ratings of FD 
and physical HRQOL. These data are in line with prior work (Emanuelson et al., 2003; Maguen et al., 
2009) suggesting PCS are one factor associated with worse health outcome ratings in individuals with 
probable mTBI. However, PCS correlated very highly with other mental health symptoms, and 
controversy exists regarding whether the etiology of PCS relates to general distress rather than to 
specific mTBI pathophysiology. The etiology of PCS in this sample cannot be conclusively attributed to 
head injury; rather, other mental and physical health conditions may relate to the PCS individuals 
reported. Moreover, other symptom self-reports each were highly correlated. This is likely due to 
multiple factors, including the high co-occurrence of measured mental health symptoms and the overlap 
in specific symptoms shared across measures. For example, depressive symptoms are assessed as part 
of the PCS, general distress, and depression-specific questionnaires; similarly irritability is shared across 
RPQ and PCL-C items. The psychiatric measures were selected to measure distinct constructs (PTSD, 
depression, anxiety/somatization), but in the current data these variables highly overlapped. As a result, 
it is not possible to evaluate the specific independent contribution of particular symptom types. The 
poorer health status outcomes reported in individuals with both probable mTBI and PTSD, as well as the 
correlation results, are consistent with a cumulative model whereby difficulties with multiple symptom 
complaints can culminate in exacerbation of disability (Brenner et al., 2009).  
In neuropsychological performance domains, performance on verbal learning and memory and 
processing speed tests differed modestly between groups. While findings of slower speed in the 
probable mTBI groups than the healthy comparison group are consistent with prior studies, we did not 
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find evidence for problems with attention or executive functioning (Frencham et al., 2005). We also did 
not find that individuals with probable mTBI/PTSD differed from those with probable mTBI only in terms 
of cognitive functioning, although higher attention and executive functioning scores were inversely 
associated with mental health variables. Thus, subtle cognitive effects were observed in those with 
probable mTBI, and cognitive performance was not significantly different in probable mTBI alone versus 
probable mTBI with comorbid PTSD. Within the probable mTBI groups, performance on psychomotor 
processing speed tests was associated with each of the health outcomes measured, while other 
cognitive domains showed more specific associations with subtypes of health outcomes (e.g., HRQOL 
with verbal learning/memory). A growing body of work recognizes the impact of psychomotor speed on 
daily functioning in other clinical disorders (Multiple Sclerosis (Costa et al., 2016); schizophrenia (Ojeda 
et al., 2012)). It is possible that slowed processing speed may most directly impact the capacity to 
complete daily activities, leading to downstream effects such as reduced productivity and efficiency, 
which impact perceived disability and life satisfaction. Importantly though, the magnitude of observed 
effects was small and the performance of each group fell within the average range. The clinical 
significance of group-based neuropsychological differences may thus be small and future research is 
needed to better understand how cognitive performance ultimately impacts daily activities in individuals 
with mTBI. 
There are a number of limitations to the current study. First, the study is cross-sectional with a 
diverse group of individuals collected across multiple study sites as part of a consortium. The parent 
trials of INTRuST included variable inclusion/exclusion criteria, and as such the nature of injury 
mechanism and associated features likely varied across study (e.g., military blast versus civilian injury). 
We did not evaluate all injury-related characteristics; participants were no longer in the acute phase of 
probable mTBI recovery, but the length of time since injury, mechanism of injury, and degree of injury-
related symptoms varied across participants and was not comprehensively assessed. Thus, we cannot 
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determine whether effects were driven by a particular injury type (e.g., blast versus blunt) or whether 
greater time since injury was associated with fewer symptoms. We also did not assess ongoing litigation. 
Although there was no obvious secondary gain to biased reporting (research records were not combined 
with clinical or forensic records) individuals’ litigation status may have impacted responding. Though the 
heterogeneity and size of the sample can be seen as a strength, results are likely not representative of a 
specific type of mTBI injury or sample (e.g., blast vs. other; military vs. civilian), and the data cannot 
predict the longitudinal course of health status outcomes over time. The method of injury assessment 
relied on a relatively brief self-report questionnaire that was based on items used in the VA TBI screener 
and Brief Traumatic Brain Injury Screen (Donnelly et al., 2011; Schwab et al., 2006) but has not been 
subject to full psychometric validation. Use of self-report data to evaluate history of mTBI injury is 
common (Carlson et al., 2011; Hoge et al., 2008), and endorsement of questionnaire items indicating 
head injury with loss of consciousness, alteration of consciousness, and posttraumatic amnesia have 
been shown to correspond well to presence of a TBI event using interview-base measures (Lau et al., 
2016). However, classification from a brief questionnaire may not fully correspond to data that would 
have been obtained from multi-source data collection (e.g., interview plus chart review), and this it may 
be possible that probable mTBI patients were miscategorized in the absence of a corresponding 
interview-based diagnosis. For example, it is possible that participants endorsed alteration of 
consciousness that were the result of other etiologies (e.g., extreme stress during trauma), resulting in 
over-identification of probable mTBI based on this item. Evaluation of mTBI history can be challenging 
under circumstances where there are no medical records to corroborate injury, but future research 
would benefit from more detailed evaluation of head injury features. We assessed FD and HRQOL using 
relatively general metrics, and thus data cannot speak to specific sources of disability (i.e., disability due 
to one disorder or another). The dataset did not include a comprehensive evaluation of all possible 
medical and psychiatric conditions of participants. As one example, the presence or absence of ADHD 
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could impact neuropsychological performance but was not assessed. It will be critical for future research 
to explore other factors that may relate to HRQOL and FD that may vary across individuals with TBI 
and/or PTSD, including diagnoses of depression and substance use. We did not include a comprehensive 
neuropsychological battery (i.e., multiple test in all domains, standalone performance validity measures) 
to fully characterize neuropsychological profiles. Though measures of performance validity (i.e., credible 
performance on neuropsychological tests) were included, we did not include metrics of symptom 
validity (i.e., measure of exaggerated or over-reporting of symptoms; (Larrabee, 2012)). Given that some 
studies suggest that symptoms may be over-reported in clinical and research settings ((Freeman et al., 
2008; Frueh et al., 2000; Tolin et al., 2010) although see (Marx et al., 2008)) it will be important for 
future research to include measures that capture potential over-endorsement of symptoms.  
Taken together, the data underscore the strong association between mental health symptoms 
and health outcomes in individuals with probable mTBI, and highlight the importance of treating these 
symptoms. PCS might be an additional intervention target but were very highly correlated with PTSD 
and other mental health symptoms, consistent with prior data supporting the substantial overlap with 
PCS and psychiatric distress. A direction for future work will be to explore the effect of psychological, 
pharmacological, or rehabilitation-focused interventions on broader health outcomes like FD and 
HRQOL among individuals with mTBI.  
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Table 1 
Baseline demographic variables and clinical characteristics by group 
 
 HC 
(n = 309) 
mTBI only 
(n = 183) 
mTBI/PTSD 
(n = 133) 
Skewness Kurtosis 
N Race 
 White 
 Black or African  American 
 Asian  
 Native Hawaiian; Pacific Islander 
 Native American ; Alaska Native  
 Other or unknown  
 
209 
55 
24 
1 
0 
20 
 
147 
22 
2 
1 
1 
10 
 
91 
27 
1 
1 
1 
12 
 
 
 
 
 
 
 
 
N Gender*** 
 Female 
 Male 
 
155 
153 
 
60 
122 
 
20 
111 
  
Mean Age*** 32.0 (11.6) 36.0 (12.2) 38.0 (10.1) 0.63 -0.67 
Mean Years Education*** 15.3 (2.7) 14.6 (2.7) 13.8 (2.1) <0.01 3.21 
Mean PCL-C*** 19.2 (4.7) 26.1 (9.2) 59.0 (12.3) 1.34 0.52 
Mean PHQ9*** 0.9 (1.5) 3.8 (4.1) 13.0 (5.8) 1.53 1.41 
Mean BSI*** 19.8 (3.0) 24.1 (7.4) 43.6 (13.8) 1.94 3.35 
Mean SDS*** 0.3 (1.3) 6.3 (8.2) 17.8 (7.6) 1.32 0.34 
Mean SF12-MCS*** 55.3 (5.0) 50.6 (8.9) 33.0 (10.2) -1.13 0.39 
Mean SF12-PCS*** 55.5 (3.7) 50.0 (10.0) 44.4 (11.1) -1.54 1.86 
Mean RPQ-3***  1.5 (2.6) 4.0 (3.1) 1.02 0.08 
Mean RPQ-13***   8.8 (11.2) 29.7 (13.0) 0.32 -1.32 
Estimated years since probable 
mTBIƗ 
 9.09 (10.78) 9.08 (9.90)   
Self reported number of probable 
mTBIsƗ 
 2.20 (3.17) 3.38 (3.36)   
N presence of LOCƗ 
   No 
   Yes 
  
37 
108 
 
 
24 
69 
 
  
Note: HC = healthy comparison participants, mTBI = participants with probable mild TBI; mTBI/PTSD = 
= participants with probable mild TBI and posttraumatic stress disorder; PCL-C = PTSD Checklist civilian 
version; PHQ9 = Patient Health Questionnaire-9; BSI = Brief Symptom Inventory; SDS = Sheehan 
Disability Scale; SF12-MCS = Mental Health quality of life; SF12-PCS = Physical health quality of life, ; 
RPQ-3 = 3-item subscale of the Rivermead Postconcussive Symptoms Questionnaire; RPQ-13 = 13-item 
subscale of the Rivermead Postconcussion Symptoms Questionnaire. Omnibus effect controlling for age 
and gender *** p < 0.001. Ɨ Injury characteristics were based on a subsample with these available 
data, n = 107, 165, and 238 respectively. 
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Table 2 
Neuropsychological performance by group  
 
 HC (n = 152) mTBI only (n = 116) mTBI/PTSD (n = 77) Skewness Kurtosis Effect size pƞ
2 
WRAT-4 score 64.00 (4.76) 64.35 (4.26) 63.30 (4.47) -1.32 2.68 0 .01 
RAVLT-2 z score 
 Total*** 
 List B***  
 Short delay recall  
 Long delay recall**  
 
0.45 (1.11) 
0.32 (1.14) 
0.26 (1.04) 
0.26 (1.01) 
 
0.00 (1.22) 
-0.11 (0.98) 
0.02 (1.39) 
-0.12 (1.25) 
 
-0.18 (0.91) 
-0.21 (0.90) 
0.00 (0.96) 
-0.15 (1.01) 
 
-0.39 
0.58 
-1.06 
-0.88 
 
0.39 
0.85 
2.00 
0.80 
 
0.06 
0.05 
0.01 
0.03 
BVMT-R t score 
 Total  
 Learning  
 Long delay recall  
 
52.91 (10.46) 
49.41 (11.22) 
52.73 (9.90) 
 
50.13 (11.54) 
50.49 (10.82) 
50.59 (11.74) 
 
50.25 (11.33) 
51.41 (11.48) 
52.37 (10.95) 
 
-0.58 
0.08 
-1.22 
 
-0.18 
-0.58 
0.79 
 
0.01 
0.01 
0.01 
Trail Making Test t score 
 Trails A*  
 Trails B   
 
53.78 (10.93) 
56.06  (11.4) 
 
49.29 (11.97) 
53.35 (11.35) 
 
50.51 (13.75) 
53.79 (13.03) 
 
0.06 
0.06 
 
-0.19 
-0.21 
 
0.03 
0.01 
WMS-III scaled score 
 L-N Sequencing 
 
11.82 (2.93) 
 
11.40 (2.76) 
 
11.13 (2.84) 
 
0.18 
 
0.36 
 
0.01 
WAIS-III scaled score 
 D-S Coding***  
 S-Search* 
 
11.39 (3.12) 
12.21 (2.68) 
 
9.83 (2.62) 
11.51 (2.57) 
 
9.06 (2.49) 
11.13 (3.03) 
 
0.26 
0.13 
 
-0.34 
0.37 
 
0.09 
0.02 
PASAT z score -0.06 (1.10) 0.09 (0.90) 0.21 (0.90) -0.66 -0.21 0.01 
Note: Individuals who did not pass embedded performance validity measures not included in table 2. HC = healthy comparison participants, 
mTBI = participants with probable mild TBI; mTBI/PTSD = participants with probable mild TBI and posttraumatic stress disorder. RAVLT-2 = Rey 
Auditory Learning Test-2; BVMT-R = Brief Visuospatial Memory Test-Revised; Trails = Trail Making Test; WMS-III = Wechsler Memory Scales-III; L-
N Sequencing = Letter-Number Sequencing; WAIS-III = Wechsler Adult Intelligence Scales-III; D-S Coding = Digit-Symbol Coding; S-Search = 
Symbol Search; PASAT = paced Auditory Serial Addition Test. N included in each subtest varied based on missing data (n range 297-353). See 
table 3 for pairwise comparisons with confidence intervals. Omnibus effects *** p < 0.001, **p <0.01, * p < 0.05. 
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Table 3 
Pairwise comparisons on demographic, clinical, and neuropsychological characteristics  
  
 HC vs. mTBI; 95% CI, p-value HC vs. mTBI/PTSD; 95% CI, p-value mTBI vs. mTBI/PTSD; 95% CI, p-value 
Age [-6.63, -1.39], 0.001* [-8.85, -2.87], <0.001* [-5.03, 1.33], ns  
Education [-0.01, 1.19], ns* [0.76, 2.15], <0.001* [0.13, 1.59], 0.01* 
PCL-C 
PHQ9 
BSI 
[-8.37 -4.54], <0.001* 
[-3.60, -1.95], <0.001* 
[-6.14, -2.51], <0.001* 
[-41.29, -36.88], <0.001* 
[-13.01, -11.11], <0.001* 
[-25.92, -21.73], <0.001* 
[-34.94, -30.32], <0.001* 
[-10.28, -8.29], <0.001* 
[-21.69, -17.31], <0.001* 
SDS 
SF12-PCS 
SF12-MCS 
[-7.13, -4.51], <0.001* 
[2.98, 6.55], <0.001* 
[2.94, 6.41], <0.001* 
[-18.92, -15.91], <0.001* 
[8.03, 12.14], <0.001* 
[20.39, 24.38], <0.001* 
[-13.17, -10.02], <0.001* 
[3.17, 7.47], <0.001* 
[15.62, 19.80], <0.001* 
RAVLT-2  
 Total 
 List B 
 Long delay recall 
 
[0.14, 0.80], 0.002* 
[0.13, 0.74], 0.002* 
[0.08, 0.73], 0.01* 
 
 
[0.21, 0.96], 0.001* 
[0.16, 0.85], 0.002* 
[0.01, 0.76], 0.04* 
 
 
[-0.28, 0.51], ns 
[-0.30, 0.44], ns 
[-0.42, 0.37], ns 
Trails A [0.74, 8.13], 0.01* [-1.35, 7.54], ns [-5.85, 3.187], ns 
WAIS-III  
 D-S Coding 
 S-Search 
  
 
[0.74, 2.40], <0.001* 
[-0.07, 1.55], ns 
 
 
[1.00, 2.96] <0.001* 
[0.003, 1.92], ns 
 
[-0.61, 1.43], ns  
[-0.77, 1.21], ns 
 
Note: HC = healthy comparison participants, mTBI = participants with probable mild TBI; mTBI/PTSD = participants with probable mild TBI and 
posttraumatic stress disorder; PCL-C = PTSD Checklist civilian version; PHQ9 = Patient Health Questionnaire; BSI = Brief Symptom Inventory; SDS 
= Sheehan Disability Scale; SF12-MCS = Mental Health quality of life; SF12-PCS = Physical health quality of life; RAVLT-2 = Rey Auditory Learning 
Test-2; WAIS-III = Wechsler Adult Intelligence Scales-III; D-S Coding = Digit-Symbol Coding; S-Search = Symbol Search. Only includes participants 
who passed PVT measures. * = survives FDR correction at p < 0.05. 
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Table 4 
Correlations between demographic variables, clinical characteristics, and FD and QOL in participants with probable mTBI and probable mTBI and 
PTSD 
 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. SDS 1           
2. SF12-PCS -0.54*** 1          
3. SF12-MCS -0.68*** 0.12* 1         
4. Age 0.18** -0.21*** -0.08 1        
5. Education -0.05 0.05 0.12* 0.12* 1       
6. Gender -0.03 0.07 0.10 -0.02 0.17** 1      
7. PCL-C 0.70*** -0.34*** -0.75*** 0.15** -0.14* -0.21*** 1     
8. PHQ9 0.76*** -0.43*** -0.82*** 0.09 -0.15** -0.09 0.78*** 1    
9. BSI 0.70*** -0.35*** -0.76*** 0.09 -0.12* -0.10 0.80*** 0.84*** 1   
10. RPQ-3 0.57*** -0.47*** -0.42*** 0.09 -0.06 0.06 0.51*** 0.57*** 0.54*** 1  
11. RPQ-13 0.73*** -0.48*** -0.65*** 0.16** -0.14* -0.14* 0.79*** 0.79*** 0.72*** 0.70*** 1 
Note: PCL-C = PTSD Checklist civilian version; PHQ9 = Patient Health Questionnaire; BSI = Brief Symptom Inventory; SDS = Sheehan Disability 
Scale; SF12-MCS = Mental Health quality of life; SF12-PCS = Physical health quality of life; RPQ-3 = 3-item subscale of the Rivermead 
Postconcussive Symptoms Questionnaire; RPQ-13 = 13-item subscale of the Rivermead Postconcussion Symptoms Questionnaire. ***p< 0.001, 
**p< 0.01, *p< 0.05. 
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Table 5.  
Correlations with health outcomes, symptoms, and cognitive performance in individuals with neuropsychological testing data in the probable 
mTBI or probable mTBI and PTSD groups 
 
 RAVLT-2 
Total 
RAVLT-2 
List B 
RAVLT-2 
Short 
recall 
RAVLT-2 
Long 
recall 
BVMT-R 
Total 
BVMT-R 
Learning 
BVMT-R 
Long 
recall 
Trail 
Making 
Test A 
Trail 
Making 
Test  B 
WMS-III 
L-N Seq 
WAIS-III 
D-S 
Coding 
 WAIS-III 
S- Search 
PASAT 
SDS -0.11  -0.07 -0.11 -0.05 -0.06 0.04 -0.12 -0.09 -0.08 0.004 -0.27***  -0.17* -0.07 
SF12-
PCS 
0.16*  -0.02 -0.16*  0.13  0.04 -0.02 0.19* 0.10 0.07 0.08 0.20** 0.22** 0.12 
SF12-
MCS 
0.04 0.04 0.01 -0.02 0.01 -0.01 -0.002 0.04 0.10 -0.01 0.20** 0.08 0.03 
PCL-C -0.12 -0.09 -0.07 -0.10 -0.03 -0.001 -0.002 0.02 -0.06 -0.07 -0.23** -0.12 -0.06 
PHQ9 -0.12 -0.10 -0.12 -0.09 -0.13 0.03 -0.15 -0.08 -0.18** -0.07 -0.20** -0.14 -0.15* 
BSI -0.12 -0.08 -0.08 -0.04 -0.09 0.03 -0.13 -0.07 -0.12 -0.07 -0.18** -0.12 -0.13 
RPQ-3 -0.17* -0.14 -0.08 -0.11 0.01 0.05 -0.02 -0.04 -0.04 -0.02 -0.09 -0.02 -0.14 
RPQ-13 -0.15 -0.11 -0.11 -0.09 -0.08 0.03 -0.04 -0.05 -0.11 -0.07 -0.24** -0.15* -0.10 
Note: PCL-C = PTSD Checklist civilian version; PHQ9 = Patient Health Questionnaire; BSI = Brief Symptom Inventory; SDS = Sheehan Disability 
Scale; SF12-MCS = Mental Health quality of life; SF12-PCS = Physical health quality of life, ; RPQ-3 = 3-item subscale of the Rivermead 
Postconcussive Symptoms Questionnaire; RPQ-13 = 13-item subscale of the Rivermead Postconcussion Symptoms Questionnaire; RAVLT-2 = Rey 
Auditory Learning Test-2; BVMT-R = Brief Visuospatial Memory Test-Revised; Trails = Trail Making Test; WMS-III = Wechsler Memory Scales-III; L-
N Sequencing = Letter-Number Sequencing; WAIS-III = Wechsler Adult Intelligence Scales-III; D-S Coding = Digit-Symbol Coding; S-Search = 
Symbol Search PASAT = Paced Auditory Serial Addition Test. ***p< 0.001, **p< 0.01, *p< 0.05. 
 
